Delivery Order SPE2DB20D6037-SPE2DB24FTWQ3
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,031.72 firm fixed-price contract is for the delivery of the drug Endometrin 100 mg vaginal inserts. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. This single-award IDC allows DLA to issue delivery orders for a wide range...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,751.73, is for the delivery of Endometrin 100 mg vaginal inserts. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $8,880.00, is for the delivery of the Mirena 52 mg contraceptive system. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,161.94 firm fixed-price delivery order is for the supply of specialized pharmaceutical products, including the Mirena 52 mg system. This award is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $34,305.12 firm fixed-price delivery order is for the supply of Etonogestrel 68 mg contraceptive implants to support the medical needs of military healthcare facilities. The award is not associated with a set-aside designation, allowing the woman-owned small business to secure this direct federal...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at up to $18,612.48, is for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at up to $13,959.36, is for the provision of a broad range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The contract has no set-aside designation. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB program. The $8,576.28 award is for the supply of Nexplanon 68 mg implants, a contraceptive product. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical items, including common medications and specialized drugs, to...